C-2-Aryl O-substituted HI-236 derivatives as non-nucleoside HIV-1 reverse-transcriptase inhibitors.
Bioorg Med Chem. 2008 Nov 1. [Epub ahead of print]
PMID: 18996020 [PubMed - as supplied by publisher]
2. Ghosh SK, Patra R, Rath SP.
Axial ligand coordination in sterically strained vanadyl porphyrins: synthesis, structure, and properties.
Inorg Chem. 2008 Nov 3;47(21):9848-56. Epub 2008 Sep 30.
PMID: 18823111 [PubMed - in process]
3. Qi Z, Shi W, Xue N, Pan C, Jing W, Liu K, Jiang S.
Rationally Designed Anti-HIV Peptides Containing Multifunctional Domains as Molecule Probes for Studying the Mechanisms of Action of the First and Second Generation HIV Fusion Inhibitors.
J Biol Chem. 2008 Oct 31;283(44):30376-84. Epub 2008 Jul 28.
PMID: 18662985 [PubMed - in process]
4. Cohen C, Forzan M, Sproat B, Pantophlet R, McGowan I, Burton D, James W.
An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site.
Virology. 2008 Nov 10;381(1):46-54. Epub 2008 Sep 17.
PMID: 18799178 [PubMed - in process]
5. Samuele A, Kataropoulou A, Viola M, Zanoli S, La Regina G, Piscitelli F, Silvestri R, Maga G.
Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complex.
Antiviral Res. 2008 Nov 1. [Epub ahead of print]
PMID: 18984007 [PubMed - as supplied by publisher]
6. Van Neck T, Pannecouque C, Vanstreels E, Stevens M, Dehaen W, Daelemans D.
Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action.
Bioorg Med Chem. 2008 Nov 1;16(21):9487-97. Epub 2008 Sep 20.
PMID: 18835718 [PubMed - in process]
7. Sapre NS, Gupta S, Pancholi N, Sapre N.
Data mining using template-based molecular docking on tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepinone (TIBO) derivatives as HIV-1RT inhibitors.
J Mol Model. 2008 Nov;14(11):1009-21. Epub 2008 Jul 19.
PMID: 18642033 [PubMed - in process]
8. Michalowski D, Chitima-Matsiga R, Held DM, Burke DH.
Novel bimodular DNA aptamers with guanosine quadruplexes inhibit phylogenetically diverse HIV-1 reverse transcriptases.
Nucleic Acids Res. 2008 Nov 7. [Epub ahead of print]
PMID: 18996899 [PubMed - as supplied by publisher]
From Ligand to Complexes. Part 2. Remarks on Human Immunodeficiency Virus type 1 Integrase Inhibition by beta-Diketo Acid Metal Complexes.
J Med Chem. 2008 Nov 5. [Epub ahead of print]
PMID: 18983138 [PubMed - as supplied by publisher]
10. Van Neck T, Pannecouque C, Vanstreels E, Stevens M, Dehaen W, Daelemans D.
Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action.
Bioorg Med Chem. 2008 Nov 1;16(21):9487-97. Epub 2008 Sep 20.
PMID: 18835718 [PubMed - in process]
Orally bioavailable prodrugs of a BCS class 2 molecule, an inhibitor of HIV-1 reverse transcriptase.
Bioorg Med Chem Lett. 2008 Nov 1. [Epub ahead of print]
PMID: 18993071 [PubMed - as supplied by publisher]
12. Asamitsu K, Yamaguchi T, Nakata K, Hibi Y, Victoriano AF, Imai K, Onozaki K, Kitade Y, Okamoto T.
Inhibition of Human Immunodeficiency Virus Type 1 Replication by Blocking I{kappa}B Kinase with Noraristeromycin.
J Biochem. 2008 Nov;144(5):581-589. Epub 2008 Aug 19.
PMID: 18713798 [PubMed - as supplied by publisher]
Towards novel S-DABOC inhibitors: Synthesis, biological investigation, and molecular modeling studies.
Bioorg Med Chem Lett. 2008 Sep 23. [Epub ahead of print]
PMID: 18842407 [PubMed - as supplied by publisher]
14. Maga G, Falchi F, Garbelli A, Belfiore A, Witvrouw M, Manetti F, Botta M.
Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3.
J Med Chem. 2008 Nov 13;51(21):6635-8. Epub 2008 Oct 4.
PMID: 18834110 [PubMed - in process]